Kevin McKernan is an expert in PCR testing. This comes from the Tom Woods Show, Episode 1765, "The PCR Testing Fiasco." From Tom's show notes, he introduces McKernan this way:
In 2000 Kevin founded Agencourt Biosciences Corporation, which specialized in manufacturing DNA and RNA purification technology known as SPRI. It became the largest private DNA sequencing company at its time and received NHGRI grants to become their fifth genome center.
Beckman Coulter acquired Agencourt in 2005 and jointly spun out Agencourt Personal Genomics, which invented and commercialized the SOLiD Sequencer. Applied Biosystems acquired ApG in 2006.
After five years with Applied Biosystems/Life tech, Kevin left to start Medicinal Genomics and Courtagen Life Sciences.
Courtagen was a high complexity CLIA lab that performed clinical diagnostic testing using PCR and sequencing.
Medicinal Genomics is a cannabis Genomics company that builds Viral and microbial PCR assays for the cannabis field.
Read the original article at TomWoods.com. http://tomwoods.com/ep-1765-the-pcr-testing-fiasco/
McKernan worked at MIT on the human genome project from 1996 to 2000.
Kary Mullis was the inventor of the PCR Test but died last year. His criticism of the PCR tests revolved around the controversy as to whether or not HIV was the only virus involved in AIDS.
New York Times article, "Your Coronavirus Test Is Positive. Maybe It Shouldn't Be."
The testing was so sensitive that for all practical purposes, the testing was not useful for anything.
The news is speaking about this problem like in earthquakes while hiding the Richter Scale. Hard to have a coherent discussion because the values in these tests aren't being shared. They're turning what is a very quantitative test into a plus, minus answer. That's the biggest problem we've got. We've got to get the CQ or the Cycle Threshold values public.
Incredibly valuable test because you can measure single molecules or a million molecules with the same test. But they're hiding these value s
No comments:
Post a Comment